Laerdal Medical India Private Limited

Laerdal Medical India Private Limited - education in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U85100MH2010PTC335728 Incorporated 31 May 2010 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company education MSME · Medium
Revenue · FY 2025
₹83.43 Cr
▲ 15% YoY
Net profit · FY 2025
₹13.93 Cr
Net margin 16.7%
EBITDA · FY 2025
₹19.83 Cr
EBITDA margin 23.8%
Authorised capital
₹68 Lakh
Registered with MCA
Paid-up capital
₹66 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Employees · EPFO
43
Provident fund records
Directors on board
4
As per MCA filings

About Laerdal Medical India Private Limited

Data last updated:

Laerdal Medical India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Laerdal Medical As. It operates in the corporate training and development segment of the education sector. It was incorporated on 31 May 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2010PTC335728. Its GSTIN is 27AABCL8105F2ZP (Maharashtra). The company holds 5 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹68 Lakh and a paid-up capital of ₹66 Lakh. It is led by directors including Sanjeev Singh and Tor Hartvig Bryne.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹83.43 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹13.93 Cr (net margin 16.7%) and EBITDA of ₹19.83 Cr (EBITDA margin 23.8%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 12% over five years.

The company has about 43 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Laerdal Medical. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 1 deal on record (1 rights issue); the latest was in January 2020. Its 7 peer companies in the Education industry (Corporate and Commercial Training, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Shree Maruti Nandan Pharmaceuticals Private Limited with revenue of ₹86.33 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier.

Laerdal Medical India Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0124365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website laerdal.com.

Company details

CIN U85100MH2010PTC335728
Registration Number 335728
Incorporation Date 31 May 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Laerdal Medical As
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0124365

CIN history

Laerdal Medical India has one previous CIN (Corporate Identification Number): U85100TN2010PTC075886. The current CIN is U85100MH2010PTC335728, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85100MH2010PTC335728Current
U85100TN2010PTC075886Previous

Recognitions & Rankings of Laerdal Medical India

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-19-0124365

Contact details

Laerdal Medical India Private Limited's registered office is in Mumbai, Maharashtra. Its website is laerdal.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    315 A 3rd Floor Kohinoor City Kirol Road Off L.B.S. Marg Kurla – Wes, T, Mumbai, Maharashtra, India – 400070
  • Industry
    Education, Corporate Training & Development

To see the full contact details of Laerdal Medical India Private Limited, buy the company report.

Comprehensive company report
Laerdal Medical India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Laerdal Medical India operates one associated brand: Laerdal Medical. Each brand links to its own profile.

BrandDescriptionWebsite
Training, education, and therapeutic products for emergency care are provided.laerdal.com

Business activity

The main business activity of Laerdal Medical India is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Laerdal Medical India Private Limited, buy the company report.

Financials of Laerdal Medical India Private Limited

FY 2025 filings available

Laerdal Medical India Private Limited reported revenue of ₹83.43 Cr (up 15% YoY) for FY 2025.

Revenue · FY 2025
₹83.43 Cr ▲ 15%
Net profit · FY 2025
₹13.93 Cr margin 16.7%
EBITDA · FY 2025
₹19.83 Cr margin 23.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 20%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 13%
5 years · compounded
▲ 40%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 15% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹19.83 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹13.93 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin23.8%
Net Profit Margin16.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Laerdal Medical India Private Limited, buy the company report.

Board of directors of Laerdal Medical India Private Limited

Laerdal Medical India has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjeev SinghDirector21 Aug 20206 Years 2 MonthsCurrent
Tor Hartvig BryneDirector05 Feb 20206 Years 9 MonthsCurrent
Unni SilkosetDirector15 Nov 20179 Years 0 MonthsCurrent
Egil MathisenDirector31 May 201016 Years 5 MonthsCurrent

Peer comparison

Laerdal Medical India Private Limited is compared with the 7 companies closest to it by revenue in the Education industry (Corporate and Commercial Training, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shree Maruti Nandan Pharmaceuticals Private Limited₹86.33 Cr (FY 2024)11.0%New Delhi, Delhi, India
Span Healthcare Private Limited₹85.92 Cr (FY 2024)40.0%Bangalore, Karnataka, India
Smiths Medical India Private Limited₹85.67 Cr (FY 2025)49.0%Mumbai, Maharashtra, India
Sibling Lifecare Private Limited₹84.54 Cr (FY 2025)20.0%Kanpur, Uttar Pradesh, India
Laerdal Medical India Private Limitedthis company₹83.43 Cr (FY 2025)₹13.93 Cr16.7%15.0%43Mumbai, Maharashtra, India
BTL India Private Limited₹80.91 Cr (FY 2025)27.0%New Delhi, Delhi, India
Curtis Drug Point Private Limited₹80.85 Cr (FY 2025)18.0%Chennai, Tamil Nadu, India
Tanyaa Modern Trade Private Limited₹79.71 Cr (FY 2025)11.0%New Delhi, Delhi, India

To see the full peer comparison of Laerdal Medical India Private Limited, buy the company report.

Auditor

Laerdal Medical India Private Limited is audited by P SINGHANIA & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
P SINGHANIA & ASSOCIATESFY 2023138354W

Shareholding

The shareholding of Laerdal Medical India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Laerdal Medical India Private Limited, buy the company report.

Deals & funding

Laerdal Medical India Private Limited has 1 deal on record (1 rights issue); the latest was in January 2020.

Total deals
1
Rights issue
1

Deals on record (1 of 1)

WhenDealAmountParties
Jan 2020Rights issue₹11.96 CrInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Laerdal Medical India Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
an individual supplier

To see the full MSME payment records of Laerdal Medical India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Laerdal Medical India Private Limited has a workforce of 43 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
43
Active EPFO establishments
1
Employee growth
-2.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2743
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18

To see the full employee and EPFO history of Laerdal Medical India Private Limited, buy the company report.

GST

Laerdal Medical India has 5 GST registrations: 3 active and 2 cancelled or inactive.

Total GSTINs
5
Active
3
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AABCL8105F2ZPMaharashtraActive01 Apr 2020
33AABCL8105F1ZXTamil NaduActive01 Jul 2017
07AABCL8105F2ZRDelhiActive01 Apr 2020

To see the full GST registrations and return filing status of Laerdal Medical India Private Limited, buy the company report.

Recent activity

Laerdal Medical India Private Limited has 14 board changes on record since 2010: 4 appointments and 10 cessations. The latest: Sanjeev Singh ceased to be Additional Director on 30 Dec 2020.

AGM
Laerdal Medical India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Laerdal Medical India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Sanjeev Singh ceased to be Additional Director.
Ceased
Tor Hartvig Bryne ceased to be Additional Director.
Appointed
Sanjeev Singh was appointed as Director.
Ceased
Sivaram ceased to be Director.
Appointed
Tor Hartvig Bryne was appointed as Director.
Ceased
Tore Laerdal ceased to be Additional Director.
Ceased
Unni Silkoset ceased to be Additional Director.
Appointed
Unni Silkoset was appointed as Director.
Ceased
William Clive Patrickson ceased to be Director.
Ceased
Muthusamy Rajaguru ceased to be Additional Director.

5 earlier events are in the company report.

Frequently asked questions

Laerdal Medical India is an active private limited company based in Mumbai, Maharashtra, India. The company works in corporate training and development, within the education industry. It was incorporated on 31 May 2010 (16+ years old) and is registered under CIN U85100MH2010PTC335728.

Laerdal Medical India has 4 current directors:

The latest financial statements of Laerdal Medical India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Laerdal Medical India is 27AABCL8105F2ZP, registered in Maharashtra. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 33AABCL8105F1ZX (Tamil Nadu), 07AABCL8105F2ZR (Delhi).

The CIN (Corporate Identification Number) of Laerdal Medical India is U85100MH2010PTC335728. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Laerdal Medical India has 1 court case on record: 1 filed by the company. 1 is pending.

Laerdal Medical India was incorporated on 31 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.

Laerdal Medical India has 1 deal on record (1 rights issue); the latest was in January 2020.

The peers of Laerdal Medical India by revenue are Shree Maruti Nandan Pharmaceuticals Private Limited, Span Healthcare Private Limited, Smiths Medical India Private Limited, Sibling Lifecare Private Limited, BTL India Private Limited and 2 more, all in the Education industry (Corporate and Commercial Training, Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).

Sanjeev Singh ceased to be Additional Director on 30 Dec 2020. Tor Hartvig Bryne ceased to be Additional Director on 30 Dec 2020. Sanjeev Singh was appointed as Director on 21 Aug 2020. Laerdal Medical India has 14 board changes on record in total.

Yes, Laerdal Medical India is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0124365).

Laerdal Medical India has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 27 Apr 2024.